Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

Close Up Scientist using microscope in laboratory room while making medical testing and research

A new radiotracer, 68Ga-FAP-2286, has been found to be more effective than the most commonly used nuclear medicine cancer imaging radiotracer, 18F-FDG. In a study published in the March issue of The Journal of Nuclear Medicine, 68Ga-FAP-2286 detected 100 percent of primary tumors across multiple cancer types as compared to 18F-FDG, which identified only 80 percent. 68Ga-FAP-2286 was also more effective in detecting lymph node metastases and distant metastases.

Using a known active ingredient as a new drug candidate against mpox

Previous article

DNA treatment could delay paralysis that strikes nearly all patients with ALS

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations